These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30056534)

  • 1. Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients.
    Sirivichayakul S; Kanchanatawan B; Thika S; Carvalho AF; Maes M
    Neurotox Res; 2019 Jan; 35(1):122-138. PubMed ID: 30056534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive deficits and its relation with psychopathology and global functioning in first episode schizophrenia.
    Hegde S; Thirthalli J; Rao SL; Raguram A; Philip M; Gangadhar BN
    Asian J Psychiatr; 2013 Dec; 6(6):537-43. PubMed ID: 24309868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL-11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-Psychiatric Disorders.
    Ivanovska M; Abdi Z; Murdjeva M; Macedo D; Maes A; Maes M
    Pharmaceuticals (Basel); 2020 Sep; 13(9):. PubMed ID: 32887304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments.
    Al-Dujaili AH; Mousa RF; Al-Hakeim HK; Maes M
    Schizophr Bull; 2021 Mar; 47(2):530-541. PubMed ID: 32971537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling.
    Kanchanatawan B; Maes M
    CNS Neurol Disord Drug Targets; 2018; 17(6):473-486. PubMed ID: 29968545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Neuropsychological Correlates in Positive and Negative Formal Thought Disorder Syndromes: The Thought and Language Disorder Scale in Endogenous Psychoses.
    Nagels A; Fährmann P; Stratmann M; Ghazi S; Schales C; Frauenheim M; Turner L; Hornig T; Katzev M; Müller-Isberner R; Grosvald M; Krug A; Kircher T
    Neuropsychobiology; 2016; 73(3):139-47. PubMed ID: 27058747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions.
    Sirivichayakul S; Kanchanatawan B; Thika S; Carvalho AF; Maes M
    CNS Neurol Disord Drug Targets; 2019; 18(2):124-140. PubMed ID: 30451122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cognitive aspect of formal thought disorder and its relationship with global social functioning and the quality of life in schizophrenia.
    Mutlu E; Abaoğlu H; Barışkın E; Gürel ŞC; Ertuğrul A; Yazıcı MK; Akı E; Yağcıoğlu AEA
    Soc Psychiatry Psychiatr Epidemiol; 2021 Aug; 56(8):1399-1410. PubMed ID: 33458782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairments and psychopathological parameters in patients of the schizophrenic spectrum.
    Kontaxaki MI; Kattoulas E; Smyrnis N; Stefanis NC
    Psychiatriki; 2014; 25(1):27-38. PubMed ID: 24739500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verbal communication impairments and cognitive control components in people with schizophrenia.
    Kerns JG
    J Abnorm Psychol; 2007 May; 116(2):279-289. PubMed ID: 17516761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of cognitive deficits and associations with depressive symptoms and intelligence in chronic early-onset schizophrenia patients.
    Jepsen JR; Fagerlund B; Pagsberg AK; Christensen AM; Nordentoft M; Mortensen EL
    Scand J Psychol; 2013 Oct; 54(5):363-70. PubMed ID: 23786210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere Length and CCL11 Levels are Associated With Gray Matter Volume and Episodic Memory Performance in Schizophrenia: Evidence of Pathological Accelerated Aging.
    Czepielewski LS; Massuda R; Panizzutti B; Grun LK; Barbé-Tuana FM; Teixeira AL; Barch DM; Gama CS
    Schizophr Bull; 2018 Jan; 44(1):158-167. PubMed ID: 28338779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between psychopathology and cognitive functioning in schizophrenia.
    Bozikas VP; Kosmidis MH; Kioperlidou K; Karavatos A
    Compr Psychiatry; 2004; 45(5):392-400. PubMed ID: 15332203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive function as predictors of persistent thought disorder in first-episode schizophrenia: a one-year follow-up study.
    Xu JQ; Hui CL; Longenecker J; Lee EH; Chang WC; Chan SK; Chen EY
    Schizophr Res; 2014 Nov; 159(2-3):465-70. PubMed ID: 25261043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social skills and behavioral problems in schizophrenia: the role of mental state attribution, neurocognition and clinical symptomatology.
    Brüne M; Schaub D; Juckel G; Langdon R
    Psychiatry Res; 2011 Nov; 190(1):9-17. PubMed ID: 20417974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].
    Lecardeur L; Meunier-Cussac S; Dollfus S
    Encephale; 2013 May; 39 Suppl 1():S64-71. PubMed ID: 23528322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive and linguistic correlates of positive and negative formal thought disorder: A meta-analysis.
    Bora E; Yalincetin B; Akdede BB; Alptekin K
    Schizophr Res; 2019 Jul; 209():2-11. PubMed ID: 31153670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased plasma levels of gasotransmitter hydrogen sulfide in patients with schizophrenia: correlation with psychopathology and cognition.
    Xiong JW; Wei B; Li YK; Zhan JQ; Jiang SZ; Chen HB; Yan K; Yu B; Yang YJ
    Psychopharmacology (Berl); 2018 Aug; 235(8):2267-2274. PubMed ID: 29777287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.